170 related articles for article (PubMed ID: 25177893)
1. [Secondary prevention of cardiovascular and cerebrovascular complications after ischemic stroke].
Ostroumova OD; Bondarets OV
Kardiologiia; 2014; 54(5):80-7. PubMed ID: 25177893
[TBL] [Abstract][Full Text] [Related]
2. Progress in clinical neurosciences: pharmacotherapies for the secondary prevention of stroke.
Hackam DG; Kapral MK
Can J Neurol Sci; 2004 Aug; 31(3):295-303. PubMed ID: 15376471
[TBL] [Abstract][Full Text] [Related]
3. Drug treatments in the secondary prevention of ischaemic stroke.
Schulz UG
Maturitas; 2013 Nov; 76(3):267-71. PubMed ID: 23769546
[TBL] [Abstract][Full Text] [Related]
4. Disparities between prescribing of secondary prevention therapies for stroke and coronary artery disease in general practice.
Heeley E; Anderson C; Patel A; Cass A; Peiris D; Weekes A; Chalmers J
Int J Stroke; 2012 Dec; 7(8):649-54. PubMed ID: 21978147
[TBL] [Abstract][Full Text] [Related]
5. Ischemic stroke in patients receiving aspirin.
Pujol Lereis VA; Ameriso S; Povedano GP; Ameriso SF
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):868-72. PubMed ID: 21703876
[TBL] [Abstract][Full Text] [Related]
6. Evaluation on the compliance with secondary prevention and influence factors of ischemic stroke in Hainan province, China.
Su Q; Yuan K; Long F; Wan Z; Li C; Cai Y; Zeng C; Wu Y; Wu H; Liu S; Li P; Zhou J; Chen C; Wang D; Yan L; Zhang Y; Dai M
Vascular; 2014 Jun; 22(3):181-7. PubMed ID: 23929417
[TBL] [Abstract][Full Text] [Related]
7. Secondary prevention of ischemic cerebrovascular disease. What is the evidence?
Paraskevas KI; Daskalopoulou SS; Daskalopoulos ME; Liapis CD
Angiology; 2005; 56(5):539-52. PubMed ID: 16193192
[TBL] [Abstract][Full Text] [Related]
8. Current and future concepts in stroke prevention.
O'Rourke F; Dean N; Akhtar N; Shuaib A
CMAJ; 2004 Mar; 170(7):1123-33. PubMed ID: 15051698
[TBL] [Abstract][Full Text] [Related]
9. Optimal combination secondary prevention drug treatment and stroke outcomes.
Park JH; Ovbiagele B
Neurology; 2015 Jan; 84(1):50-6. PubMed ID: 25411440
[TBL] [Abstract][Full Text] [Related]
10. Secondary prevention after ischemic stroke.
Jaff MR; White CJ
N Engl J Med; 2012 Aug; 367(7):675-6; author reply 676-7. PubMed ID: 22894587
[No Abstract] [Full Text] [Related]
11. Secondary prevention after ischemic stroke.
Zhang H; Messerli FH; Staessen JA
N Engl J Med; 2012 Aug; 367(7):675; author reply 676-7. PubMed ID: 22894586
[No Abstract] [Full Text] [Related]
12. [The management of cerebrovascular events].
Sène Diouf F; Ndiaye MM
Dakar Med; 2008; 53(1):7-19. PubMed ID: 19102112
[TBL] [Abstract][Full Text] [Related]
13. [Stroke in chronic renal failure].
Bereczki D
Orv Hetil; 2008 Apr; 149(15):691-6. PubMed ID: 18387873
[TBL] [Abstract][Full Text] [Related]
14. [Preventive cardiovascular recommendations].
Maiques Galán A; Villar Alvarez F; Brotons Cuixart C; Torcal Laguna J; Orozco-Beltrán D; Navarro Pérez J; Lobos-Bejarano JM; Banegas Banegas JR; Ortega Sánchez-Pinilla R; Gil Guillén V; Solana Saura P;
Aten Primaria; 2007 Nov; 39 Suppl 3():15-26. PubMed ID: 19288694
[No Abstract] [Full Text] [Related]
15. (8) Cardiovascular disease and risk management.
American Diabetes Association
Diabetes Care; 2015 Jan; 38 Suppl():S49-57. PubMed ID: 25537708
[No Abstract] [Full Text] [Related]
16. [Secondary prevention of ischemic non cardioembolic stroke].
Armario P; Pinto X; Soler C; Cardona P
Clin Investig Arterioscler; 2015; 27(6):287-300. PubMed ID: 25771074
[TBL] [Abstract][Full Text] [Related]
17. A polypill for all? Critical review of the polypill literature for primary prevention of cardiovascular disease and stroke.
Carey KM; Comee MR; Donovan JL; Kanaan AO
Ann Pharmacother; 2012 May; 46(5):688-95. PubMed ID: 22570437
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici MG; Mattle HP; Rothwell PM;
Cerebrovasc Dis; 2009; 27(5):509-18. PubMed ID: 19372653
[TBL] [Abstract][Full Text] [Related]
19. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack.
Davis SM; Donnan GA
N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297
[No Abstract] [Full Text] [Related]
20. Antiplatelet activity of drugs used in hypertension, dyslipidemia and diabetes: Additional benefit in cardiovascular diseases prevention.
Sepúlveda C; Palomo I; Fuentes E
Vascul Pharmacol; 2017 Apr; 91():10-17. PubMed ID: 28342822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
